At 15 weeks after shRNA application, we evaluated the level of mRNA and protein for HTT and ATXN3 in HD and SCA3 mice, respectively, in several brain structures (Figures 2B–2E and 3B–3E). This evidence concerns the gene HTT and Huntington disease.